248 related articles for article (PubMed ID: 20070483)
1. Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.
Shen LC; Chen YK; Hsue SS; Shaw SY
J Oral Pathol Med; 2010 Mar; 39(3):242-9. PubMed ID: 20070483
[TBL] [Abstract][Full Text] [Related]
2. Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.
Zhang B; Zhang J; Huang HZ; Xu ZY; Xie HL
J Oral Pathol Med; 2010 Mar; 39(3):219-22. PubMed ID: 19709349
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of matrilysins (MMP-7 and MMP-26) in ameloblastomas and adenomatoid odontogenic tumors.
Souza Freitas V; Ferreira de Araújo CR; Alves PM; de Souza LB; Galvão HC; de Almeida Freitas R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):417-24. PubMed ID: 19570695
[TBL] [Abstract][Full Text] [Related]
4. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase in ameloblastoma].
Zhong M; Han YP; Wang J; Li ZJ; Bao G; Yue YL
Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):427-31. PubMed ID: 14966582
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor.
Ribeiro BF; Iglesias DP; Nascimento GJ; Galvão HC; Medeiros AM; Freitas RA
Oral Dis; 2009 Oct; 15(7):472-7. PubMed ID: 19522745
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma.
Yoon HJ; Jo BC; Shin WJ; Cho YA; Lee JI; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):767-76. PubMed ID: 22014999
[TBL] [Abstract][Full Text] [Related]
8. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity.
Pinheiro JJ; Freitas VM; Moretti AI; Jorge AG; Jaeger RG
Histopathology; 2004 Jul; 45(1):65-72. PubMed ID: 15228445
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M
Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139
[TBL] [Abstract][Full Text] [Related]
10. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
Stojic J; Hagemann C; Haas S; Herbold C; Kühnel S; Gerngras S; Roggendorf W; Roosen K; Vince GH
Neurosci Res; 2008 Jan; 60(1):40-9. PubMed ID: 17980449
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
13. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
14. [The study of the invasive biologic behavior of ameloblastoma].
Zhong M; Li ZJ; Wang J; Yue YL; Bao G
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Jan; 39(1):45-8. PubMed ID: 14989873
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human monocyte matrix metalloproteinases by SPARC.
Shankavaram UT; DeWitt DL; Funk SE; Sage EH; Wahl LM
J Cell Physiol; 1997 Dec; 173(3):327-34. PubMed ID: 9369945
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of matrix metalloproteinases 1, 2, and 9 in odontogenic myxoma and dental germ papilla.
Nonaka CF; Augusto Vianna Goulart Filho J; Cristina da Costa Miguel M; Batista de Souza L; Pereira Pinto L
Pathol Res Pract; 2009; 205(7):458-65. PubMed ID: 19243899
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip.
Barros SS; Henriques ÁC; Pereira KM; de Medeiros AM; Galvão HC; Freitas Rde A
Arch Oral Biol; 2011 Aug; 56(8):752-60. PubMed ID: 21255765
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
[TBL] [Abstract][Full Text] [Related]
20. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]